Skip to content

13F-HR filed by SPHERA FUNDS MANAGEMENT LTD.

SPHERA FUNDS MANAGEMENT LTD. filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 57 holding rows worth $934,859,000.

Accession
0001496201-22-000007
Filed
2022-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2022

A holdings report, 57 entries on the cover page, a total value of $934,859,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $934,859,000 with VALUE read as thousands by filing date, 13F file number 028-15863. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INVESCO QQQ TR46090E103COM992,800$278,262,000thousands by filing datecall
SPY78462F103SHS199,500$75,261,000thousands by filing datecall
ASTRAZENECA PLC SPONSORED ADR046353108ADR798,610$52,764,000thousands by filing date
Johnson & Johnson478160104COM276,451$49,073,000thousands by filing date
Eli Lilly and Company532457108COM132,250$42,879,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR846,215$42,336,000thousands by filing date
AbbVie,Inc.00287Y109COM218,385$33,448,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH437,748$32,512,000thousands by filing date
NOVO-NORDISK A S ADR670100205ADR261,440$29,132,000thousands by filing date
Merck & Co.,Inc.58933Y105COM285,000$25,983,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR3,381,600$25,430,000thousands by filing datecall
SYNDAX PHARMACEUTICALS INC87164F105COM1,139,329$21,921,000thousands by filing date
ALTIMMUNE INC02155H200COM NEW1,392,884$16,297,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH200,000$14,854,000thousands by filing datecall
SPRINGWORKS THERAPEUTICS INC85205L107COM536,664$13,213,000thousands by filing date
FIVE9 INC338307101COM140,968$12,848,000thousands by filing date
CHINOOK THERAPEUTICS INC16961L106COM643,731$11,259,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock586,820$10,944,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock75,000$10,939,000thousands by filing datecall
NICE LTD SPONSORED ADR653656108ADR55,482$10,678,000thousands by filing date
MERUS N VN5749R100COM409,161$9,263,000thousands by filing date
IVERIC BIO INC46583P102COM962,470$9,259,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock494,595$9,066,000thousands by filing date
RELMADA THERAPEUTICS INC75955J402COMMON STOCK466,830$8,865,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,147,878$8,632,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM753,037$8,088,000thousands by filing date
META PLATFORMS INC CL A30303M102COM50,000$8,063,000thousands by filing date
IMMATICS N.VN44445109SHS730,712$6,365,000thousands by filing date
INOZYME PHARMA INC45790W108COM1,165,600$5,560,000thousands by filing date
C4 THERAPEUTICS INC12529R107COM STK705,736$5,321,000thousands by filing date
FIVERR INTL LTD33835LAA3NOTE 11/04,951,000$3,786,000thousands by filing date
REZOLUTE INC76200L309COMMON STOCK1,155,897$3,734,000thousands by filing date
VISTAGEN THERAPEUTICS INC92840H202COM3,291,135$2,896,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM679,400$2,860,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK2,525,000$2,853,000thousands by filing date
PMV PHARMACEUTICALS INC69353Y103COM187,800$2,676,000thousands by filing date
Visa Inc92826C839COM12,600$2,481,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM299,654$2,478,000thousands by filing date
Airbnb, Inc. Class A009066101COM27,700$2,468,000thousands by filing date
WEREWOLF THERAPEUTICS INC95075A107CMN597,003$2,442,000thousands by filing date
INVESCO QQQ TR46090E103COM8,186$2,294,000thousands by filing date
IVERIC BIO INC46583P102COM200,000$1,924,000thousands by filing datecall
KEROS THERAPEUTICS INC COM492327101Stock67,997$1,879,000thousands by filing date
NVIDIA Corp67066G104COM11,288$1,711,000thousands by filing date
89BIO INC282559103COM450,000$1,449,000thousands by filing date
MAGIC SOFTWARE ENTERPRISES LTD ORD559166103Stock81,293$1,445,000thousands by filing date
VISTAGEN THERAPEUTICS INC92840H202COM1,500,000$1,320,000thousands by filing datecall
Advanced Micro Devices,Inc.007903107COM15,773$1,206,000thousands by filing date
KINNATE BIOPHARMA INC49705R105COM91,673$1,156,000thousands by filing date
ONCORUS INC68236R103COM540,258$681,000thousands by filing date
NICE SYS INC65366HAB9BOND250,000$588,000thousands by filing date
WIX COM LTD92940WAD1NOTE 8/1700,000$566,000thousands by filing date
GENERAC HLDGS INC368736104COM2,310$486,000thousands by filing date
OTONOMO TECHNOLOGIES LTDM7571L103ORDINARY SHARES391,863$431,000thousands by filing date
ARBE ROBOTICS LTD ORDINARY SHARESM1R95N100Stock43,165$237,000thousands by filing date
IMMATICS N.VN44445117*W EXP 07/01/202100,000$204,000thousands by filing date
VINCERX PHARMA INC92731L106COM NEW70,467$93,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001496201-22-000007this filing2022-08-15acceptance time not in the bulk data set